Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 1863 entries
View as:

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Phase: N/A Priority: Normal
NCT ID: NCT05640843 Org: User:
Start: 11/29/22 End: 11/30/26 Due: 11/30/27

Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01591772 Org: User:
Start: 04/24/12 End: 05/25/22 Due: 05/25/23

Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT02145143 Org: User:
Start: 05/20/14 End: 11/21/24 Due: 11/21/25

Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00074009 Org: User:
Start: 10/31/03 End: - Due: -

Identification of New Colorectal Cancer Genes

Phase: N/A Priority: Normal
NCT ID: NCT00582335 Org: User:
Start: 02/10/98 End: 12/17/21 Due: 12/17/22

Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values

Phase: N/A Priority: Normal
NCT ID: NCT04942717 Org: User:
Start: 06/18/21 End: 06/18/26 Due: 06/18/27

Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently

Phase: N/A Priority: Normal
NCT ID: NCT03496181 Org: User:
Start: 03/30/18 End: 05/08/25 Due: 05/08/26

Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities

Phase: N/A Priority: Normal
NCT ID: NCT02406274 Org: User:
Start: 03/31/15 End: 06/27/24 Due: 06/27/25

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004065 Org: User:
Start: 07/31/99 End: 03/31/05 Due: 03/31/06

Ro 31-7453 in Treating Patients With Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00014365 Org: User:
Start: 10/31/00 End: 10/31/01 Due: 10/31/02

Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites

Phase: N/A Priority: Normal
NCT ID: NCT01188746 Org: User:
Start: 08/31/10 End: 02/29/20 Due: 02/28/21

Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI

Phase: N/A Priority: Normal
NCT ID: NCT01297231 Org: User:
Start: 02/28/11 End: 02/28/14 Due: 02/28/15

Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection

Phase: N/A Priority: Normal
NCT ID: NCT02770326 Org: User:
Start: 05/10/16 End: 02/16/24 Due: 02/16/25

Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type

Phase: N/A Priority: Normal
NCT ID: NCT03728972 Org: User:
Start: 11/09/18 End: 11/30/25 Due: 11/30/26

Image-Guided Navigation for High Dose Rate Temporary Interstitial Brachytherapy in the Palliative Management of Previously Treated Tumors of the Spine and Pelvis

Phase: N/A Priority: Normal
NCT ID: NCT01757717 Org: User:
Start: 01/31/13 End: 07/31/17 Due: 07/31/18

Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04792073 Org: User:
Start: 03/08/21 End: 03/31/26 Due: 03/31/27

Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)

Phase: N/A Priority: Normal
NCT ID: NCT02605486 Org: User:
Start: 11/11/15 End: 11/30/25 Due: 11/30/26

Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00375518 Org: User:
Start: 07/31/06 End: 05/31/14 Due: 05/31/15

Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT00629798 Org: User:
Start: 02/12/08 End: 10/20/20 Due: 10/20/21

Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

Phase: N/A Priority: Normal
NCT ID: NCT04469075 Org: User:
Start: 07/09/20 End: 07/31/25 Due: 07/31/26

ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00077246 Org: User:
Start: 09/30/03 End: - Due: -

BRCA Founder OutReach (BFOR) Study

Phase: N/A Priority: Normal
NCT ID: NCT03351803 Org: User:
Start: 11/10/17 End: 05/10/26 Due: 05/10/27

Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT02783625 Org: User:
Start: 05/31/16 End: 05/31/26 Due: 05/31/27

GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00521014 Org: User:
Start: 10/31/07 End: 07/31/13 Due: 07/31/14

Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT04384146 Org: User:
Start: 05/07/20 End: 05/31/26 Due: 05/31/27